InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,399.22
(
-0.51%
)
US TECH 100
18,511.60
(
0.99%
)
Dow Jones
39,935.07
(
0.20%
)
Brent Oil
81.19
(
-0.42%
)
Bitcoin
67,182.42
(
2.12%
)
Post# of 14689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

WeeZuhl

Send PM Follow Ignore
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

WeeZuhl

Re: None

Saturday, 05/02/2015 11:03:08 AM

Saturday, May 02, 2015 11:03:08 AM

Post# of 14689

The Company plans to disclose the latest results from the Phase II clinical trial at this year's American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago from May 29 to June 2, 2015.



http://investor.generex.com/releasedetail.cfm?ReleaseID=896630

But go to the ASCO library site and search the abstracts...

https://iplanner.asco.org/am2015/AM2015.aspx

I got zero results searching for AE37, mittendorf, generex, and many other permutations. I've heard of ASCO embargos on data, but not on abstracts and presenters. We'll know in less than one month: was the February PR about an ASCO presentation a complete fabrication?

If so, then it's time for the true scientists associated with Generex and Antigen Express to stand up and call for the resignation of Mark Fletcher.

Dr. Eric von Hofe, Dr. James H. Anderson, Dr. Gerald Bernstein, Dr. George E. Peoples, Dr. Joseph Rubinfeld-- I'm looking at you!

"There are three kinds of lies: lies, damned lies, and statistics."

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up